DEXamethasone EARLY administration in hospitalized patients with Covid-19 pneumonia : DEXamethasone EARLY administration in hospitalized patients with Covid-19 pneumonia and high risk of developing acute respiratory distress syndrome - EARLY-DEX Covid-19

Media Type:

Clinical Trial

Year of Publication:

2021

Publication:

2021

Contained In:

WHO International Clinical Trials Registry Platform - (2021) vom: 07. Sept. To Main Record - year:2021

Language:

Unbestimmt

Links:

Volltext [kostenfrei]

Keywords:

610
Medical Condition: Hospitalized patients with Covid-19 pneumonia who do not require oxygen therapy on admission associated with at least two of the three following factors related with severe Covid-19: lactate dehydrogenase > 245 U/L, C-reactive protein > 100 mg/L and lymphocyte count < 800 cells/µL.;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Phase: Phase 4
Recruitment Status: Authorised-recruitment may be ongoing or finished
Study Type: Interventional

Notes:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 01-09-2021, Last updated: 2021-09-13

PPN (Catalogue-ID):

WHO00788804X